Complamin,
Complamine,
Komplamin,
Niacinate, Xanthinol,
Nicotinate, Xanthinol,
Nicotinate, Xantinol,
Sadamin,
Sadamine,
Teonicol,
Xanthinol Niacinate,
Xanthinol Nicotinate,
Xantinol Nicotinate,
Xantinol-nicotinat-ratiopharm,
Xavin,
Xanthinol nicotinate,
XANTHINOL NIACINATE,
437-74-1,
Xantinol nicotinate,
Complamin,
Angioamin,
Complamex,
Contamex,
Landrina,
Sadamine,
Stenalgil,
Teonicol,
Xanidil,
Vedrin,
Complamin retard,
Angiomin,
Sadamin,
Xavin,
SK 331 A,
Xanthinolium nicotinicum,
Xanthinol niacinate [USAN],
Xantinolo nicotinato [DCIT],
Xantinoli nicotinas [INN-Latin],
EINECS 207-115-7,
Nicotinate de xantinol [INN-French],
Nicotinato de xantinol [INN-Spanish],
Methoxylin, compd. with nicotinic acid,
NSC 113217,
Xanthinol niacinate (USAN),
MLS000028609,
SK 331A,
NSC113217,
NCGC00021151-02,
SMR000058741,
7-(3-(N-(2-Hydroxyethyl)amino)-2-hydroxypropyl)thiophylline nicotinate,
7-(2-Hydroxy-3-((2-hydroxyethyl)methylamino)propyl)theophylline compd. with nicotinic acid,
7- 2-Hydroxy-3-((2-hydroxyethyl)methylamino)propyl theophylline, compound with nicotinic acid (1:1),
C19H26N6O6,
Xantinoli nicotinas,
3-Pyridinecarboxylic acid compd. with 3,7-dihydro-7-(2-hydroxy-3-((2-hydroxyethyl)methylamino)propyl)-1,3-dimethyl-1H-purine-2,6-dione (1:1),
7-[2-hydroxy-3-[2-hydroxyethyl(methyl)amino]propyl]-1,3-dimethyl-purine-2,6-dione; nicotinic acid,
7-{2-Hydroxy-3-((2-hydroxyethyl)methylamino)propyl}theophylline, compound with nicotinic acid (1:1),
Nicotinic acid, compd. with 3,7-dihydro-7-(2-hydroxy-3-((2-hydroxyethyl) methylamino)propyl)-1,3-dimethyl-1H-purine-2,6-dione,
Nicotinic acid, compd. with 7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]theophylline (1:1),
Xantinolo nicotinato,
Nicotinate de xantinol,
Nicotinato de xantinol,
sk 331-a,
Complamine,
Komplamin,
Complamin (TN),
7-(2-hydroxy-3-((2-hydroxyethyl)(methyl)amino)propyl)-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione nicotinate,
7-[2-Hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]theophylline, compound with nicotinic acid (1:1),
7-[2-hydroxy-3-[2-hydroxyethyl(methyl)amino]propyl]-1,3-dimethylpurine-2,6-dione;pyridine-3-carboxylic acid,
C13H21N5O4.C6H5NO2,
Opera_ID_260,
AC1Q5UAY,
niacin xanthinol niacinate,
DSSTox_CID_3743,
Xantinol Nicotinate ,(S),
Xantinol nicotinate [INN],
AC1L1U3H,
DSSTox_RID_77178,
DSSTox_GSID_23743,
MLS001148608,
MLS001424204,
MLS006010909,
ARONIS24311,
SCHEMBL121655,
CHEMBL1560089,
DTXSID0023743,
BBC/467,
HMS2052E09,
HMS2230J12,
HMS3371O12,
HMS3394E09,
ZX-AS004671,
Tox21_110866,
MFCD00058342,
SBB080746,
AKOS005267237,
API0004619,
CCG-101097,
NC00347,
NSC-113217,
NCGC00164435-01,
AN-44884,
AS-11613,
BC681140,
CAS-437-74-1,
CPD000058741,
LS-96554,
SAM001246912,
SC-18608,
FT-0603393,
D06334,
J10010,
C-22290,
SR-01000000242,
SR-01000000242-4,
3-Pyridinecarboxylic acid compd. with 3,3-dimethyl-1H-purine-2,6-dione (1:1),
{7-[2-Hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]theophylline,} compound with nicotinic acid (1:1),
3-Pyridinecarboxylic acid & {3,7-dihydro-7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]-1,} 3-dimethyl-1H-purine-2,6-dione (1:1),
3-Pyridinecarboxylic acid, compd. with 3, {7-dihydro-7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]-1,} 3-dimethyl-1H-purine-2,6-dione (1:1),
3-Pyridinecarboxylic acid, compd. with 3,7-dihydro-7-(2-hydroxy-3-((2-hydroxyethyl)methylamino)propyl)-1,3-dimethyl-1H-purine-2,6-dione (1:1),
3-Pyridinecarboxylic acid,7-dihydro-7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]-1,3-dimethyl-1H-purine-2,6-dione (1:1),
7-[2-hydroxy-3-[2-hydroxyethyl(methyl)amino]propyl]-1,3-dimethylpurine-2,6-dione; pyridine-3-carboxylic acid,
7-{2-hydroxy-3-[(2-hydroxyethyl)(methyl)amino]propyl}-1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione; pyridine-3-carboxylic acid,
7-{2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl}-1,3-dimethyl-1,3,7-trihydr opurine-2,6-dione, pyridine-3-carboxylic acid,
Nicotinic acid compound with 7-(2-hydroxy-3-((2-hydroxyethyl)(methyl)amino)propyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione (1:1),
Nicotinic acid, compd. with {7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]theophylline} (1:1),
Nicotinic acid, compd. with 3,7-dihydro-7-(2-hydroxy-3-((2-hydroxyethyl)methylamino)propyl)-1,3-dimethyl-1H-purine-2,6-dione,
Nicotinic acid, compd. with 7-(2-hydroxy-3-((2-hydroxyethyl)methylamino)propyl)theophylline(1:1),
Nicotinic acid, compd. with 7-(2-hydroxy-3-((2-hydroxyethyl)methylamino)propyl)theophylline(1:1) (8CI),
pyridine-3-carboxylic acid - 7-{2-hydroxy-3-[(2-hydroxyethyl)(methyl)amino]propyl}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione (1:1),
Xanthinol,
Xanthinolnicotinate,
Xanthinol Nicotinate?,
UNII-8G60H12X2D,
DEA No. 2772,
CID9912,
8G60H12X2D,
AR-1L4261,
C13-H21-N5-O4.C6-H5-N-O2,
7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]theophylline compd with nicotinic acid,
3-Pyridinecarboxylic acid, compound with 3,7-dihydro-7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]-1,3-dimethyl-1H-purine-2,6-dione (1:1),
473-98-3,
nicotinic acid - 7-{2-hydroxy-3-[(2-hydroxyethyl)(methyl)amino]propyl}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione (1:1),